Janssen Enters Worldwide Collaboration and License Agreement with Chinese Company Legend Biotech to Develop Investigational CAR-T Anti-Cancer Therapy

HORSHAM, Pa., /PRNewswire/ -- Janssen Biotech, Inc. ("Janssen"), a Janssen Pharmaceutical Company of Johnson & Johnson, announced today that it has entered into a worldwide collaboration and license agreement with Legend Biotech USA Inc.

本帖由Pocket通过IFTTT自动生成。
阅读全文，请点击： Janssen Enters Worldwide Collaboration and License Agreement with Chinese Company Legend Biotech to Develop Investigational CAR-T Anti-Cancer Therapy
（注：如原文链接失效，请留言让我知晓，我们将修改链接至有效的源。）